Find Expert Doctors on Chronic Neutrophilic Leukemia203 top medical experts on Chronic Neutrophilic Leukemia across 15 countries and 16 U.S. states, including 78 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Chronic Neutrophilic Leukemia: A rare myeloproliferative disorder that is characterized by a sustained, mature neutrophilic leukocytosis. No monocytosis, eosinophilia, or basophilia is present, nor is there a philadelphia chromosome or bcr-abl fusion gene (genes, ABL).
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Chronic Disease (3,303), Myeloproliferative Disorders (3,110).
- Clinical Trials
: at least 21 including 2 Active, 16 Completed, 1 Recruiting
- Pollyea, Daniel A Hematology & Oncology
Division of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado School of Medicine, Aurora, CO.Disclosed payments in 2021 from 27 biomedical companies, totalling $47,614.15, including $21,471.92 from AbbVie Inc.Subjects: Leukemia, Neutrophilic, Chronic; Hematologic Neoplasms; Mutation; Receptors, Colony-Stimulating Factor; Carrier Proteins; Clonal EvolutionCategories: Genetics; Diagnosis; Drug Therapy; Therapeutic Use - Gotlib, Jason R Hematology Division of Hematology, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, California. Top HospitalDisclosed payments in 2021 from 7 biomedical companies, totalling $13,104.5, including $8,004.5 from Blueprint Medicines CorporationSubjects: Leukemia, Neutrophilic, Chronic; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Hematologic Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myelomonocytic, Chronic; MutationCategories: Diagnosis; Genetics; Drug Therapy; Therapeutic Use
- Druker, Brian J Hematology & Oncology Knight Cancer Institute, Oregon Health & Science University, Portland, OR. Top HospitalMedical school: University of California, San Diego School of Medicine (MD, 1981)Medicare AcceptedDisclosed payments in 2021 from 92 biomedical companies, totalling $187,842.22, including $161,673.86 from Amgen Inc.Subjects: Leukemia, Neutrophilic, Chronic; Hematologic Neoplasms; Receptors, Colony-Stimulating Factor; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; MutationCategories: Genetics; Metabolism; Diagnosis; Drug Therapy; Therapeutic Use
- Tefferi, Ayalew Hematology Department of Internal Medicine, Division of Hematology, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA. . Top HospitalSubjects: Leukemia, Neutrophilic, Chronic; Receptors, Colony-Stimulating Factor; Carrier Proteins; Mutation; Nuclear Proteins; Amino Acid SubstitutionCategories: Genetics; Diagnosis; Therapy; Therapeutic Use; Antagonists & Inhibitors; Complications
- Collins, Robert H Hematology & Oncology Hematology/Oncology, The University of Texas Southwestern Medical Center, Dallas, TX. Top HospitalDisclosed payments in 2021 from 2 biomedical companies, totalling $500.24, including $455.24 from Servier Pharmaceuticals LLCSubjects: Leukemia, Neutrophilic, Chronic; Hematologic Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Mutation; PyrazolesCategories: Genetics; Diagnosis; Drug Therapy; Therapeutic Use
- Oh, Stephen T Hematology Division of Hematology, Department of Medicine, Washington University in St Louis, St Louis, MO.Disclosed payments in 2021 from 7 biomedical companies, totalling $10,065, including $5,265 from Incyte CorporationSubjects: Leukemia, Neutrophilic, Chronic; Hematologic Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Mutation; PyrazolesCategories: Genetics; Diagnosis; Drug Therapy; Therapeutic Use
- Avalos, Belinda R Internal Medicine Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. Electronic address: .Physician Case ReportsSubjects: Leukemia, Neutrophilic, Chronic; Receptors, Colony-Stimulating Factor; Germ-Line Mutation; Mutation, Missense; Oncogenes; Signal TransductionCategories: Genetics; Metabolism
- Press, Richard D Molecular Genetic Pathology Department of Pathology, Oregon Health & Science University, Portland, OR. Top HospitalPhysician Clinical TrialDisclosed payments in 2021 from 3 biomedical companies, totalling $4,350, including $2,850 from NOVARTIS PHARMACEUTICALS CORPORATIONSubjects: Leukemia, Neutrophilic, Chronic; Pyrazoles; Antineoplastic Agents; Clonal Evolution; Leukemia, Myelogenous, Chronic, BCR-ABL PositiveCategories: Drug Therapy; Therapeutic Use; Drug Effects; Genetics
- Hanson, Curtis A Hematology Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Top HospitalPhysicianSubjects: Leukemia, Neutrophilic, Chronic; Receptors, Colony-Stimulating Factor; Carrier Proteins; Leukemia, Myelomonocytic, Chronic; Mutation; Nuclear ProteinsCategories: Genetics; Diagnosis
- Steensma, David P Hematology & Oncology Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Top HospitalPhysician Case ReportsDisclosed payments from biomedical company (Otsuka Pharmaceutical Co., Ltd.) in 2021 for $1,800Subjects: Leukemia, Neutrophilic, Chronic; Hematologic Neoplasms; Mutation; Pyrazoles; Receptors, Colony-Stimulating FactorCategories: Genetics; Diagnosis; Drug Therapy; Therapeutic Use
- Maxson, Julia E Knight Cancer Institute, Oregon Health & Science University, Portland, OR. Top HospitalRelevant US NIH Grant Funding: $483,947 over the last 5 yearsSubjects: Leukemia, Neutrophilic, Chronic; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Receptors, Colony-Stimulating Factor; Hematologic Neoplasms; Mutation; PyrazolesCategories: Genetics; Diagnosis; Metabolism; Drug Therapy; Therapeutic Use; Drug Effects
- Tyner, Jeffrey W Knight Cancer Institute, Oregon Health & Science University, Portland, OR. Top HospitalRelevant US NIH Grant Funding: $639,100 over the last 5 yearsSubjects: Leukemia, Neutrophilic, Chronic; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Receptors, Colony-Stimulating Factor; Hematologic Neoplasms; Mutation; PyrazolesCategories: Genetics; Diagnosis; Metabolism; Drug Therapy; Therapeutic Use; Drug Effects
- Hasserjian, Robert P Hematology Massachusetts General Hospital. Top HospitalPhysician Case ReportsMedical school: Harvard Medical School (MD, 1990)Medicare AcceptedSubjects: Leukemia, Neutrophilic, Chronic; Bone Marrow; Leukemia, Myeloid; Leukocytosis; Myeloproliferative Disorders; Receptors, Colony-Stimulating FactorCategories: Pathology; Etiology; Genetics
- Deininger, Michael W Hematology Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. Top HospitalPhysicianDisclosed payments in 2021 from 13 biomedical companies, totalling $23,907.5, including $12,117.5 from Novartis Pharmaceuticals CorporationSubjects: Leukemia, Neutrophilic, Chronic; Hematologic Neoplasms; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Mutation; Receptors, Colony-Stimulating FactorCategories: Genetics; Diagnosis
- Price, Andrea E Gynecology Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.Physician Case ReportsMedical school: Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University (MD, 1991)Disclosed payments in 2021 from 10 biomedical companies, totalling $140.69, including $109.75 from AbbVie Inc.Subjects: Leukemia, Neutrophilic, Chronic; Receptors, Colony-Stimulating Factor; Germ-Line Mutation; Mutation, Missense; Oncogenes; Signal TransductionCategories: Genetics; Metabolism
- Fathi, Amir T Hematology & Oncology Physician Case ReportsDisclosed payments in 2021 from 24 biomedical companies, totalling $68,174.66, including $19,000 from Takeda Pharmaceuticals U.S.A., Inc.Subjects: Bone Marrow; Leukemia, Neutrophilic, Chronic; Leukocytosis; Receptors, Colony-Stimulating FactorCategories: Pathology; Etiology; Genetics
- Xiao, Zhijian MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 288 Nanjing Road, Tianjin 300020, China. .PhysicianSubjects: Leukemia, Neutrophilic, Chronic; Biomarkers, Tumor; Calreticulin; Carrier Proteins; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Leukemia, Myelomonocytic, ChronicCategories: Genetics
- Cui, Yajuan MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 288 Nanjing Road, Tianjin 300020, China..PhysicianSubjects: Leukemia, Neutrophilic, Chronic; Biomarkers, Tumor; Calreticulin; Carrier Proteins; Mutation; Nuclear ProteinsCategories: Genetics
- Dao, Kim-Hien T Knight Cancer Institute, Oregon Health & Science University, Portland, OR. Top HospitalSubjects: Leukemia, Neutrophilic, Chronic; Hematologic Neoplasms; Pyrazoles; Antineoplastic Agents; Clonal Evolution; Leukemia, Myelogenous, Chronic, BCR-ABL PositiveCategories: Diagnosis; Drug Therapy; Genetics; Therapeutic Use; Drug Effects
- Radich, Jerald ScientistSubjects: Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Leukemia, Neutrophilic, Chronic; Mutation; Receptors, Colony-Stimulating FactorCategories: Genetics
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.